Sans Merce M, Ruiz N, Barth I, Carnicer A, Donadille L, Ferrari P, Fulop M, Ginjaume M, Gualdrini G, Krim S, Mariotti F, Ortega X, Rimpler A, Vanhavere F, Baechler S
Institute of Radiation Physics, University Hospital Center of Lausanne, Grand-pré 1, 1007 Lausanne, Switzerland.
Radiat Prot Dosimetry. 2011 Mar;144(1-4):515-20. doi: 10.1093/rpd/ncq574. Epub 2011 Jan 12.
The Work Package 4 of the ORAMED project, a collaborative project (2008-11) supported by the European Commission within its seventh Framework Programme, is concerned with the optimisation of the extremity dosimetry of medical staff in nuclear medicine. To evaluate the extremity doses and dose distributions across the hands of medical staff working in nuclear medicine departments, an extensive measurement programme has been started in 32 nuclear medicine departments in Europe. This was done using a standard protocol recording all relevant information for radiation exposure, i.e. radiation protection devices and tools. This study shows the preliminary results obtained for this measurement campaign. For diagnostic purposes, the two most-used radionuclides were considered: (99m)Tc and (18)F. For therapeutic treatments, Zevalin(®) and DOTATOC (both labelled with (90)Y) were chosen. Large variations of doses were observed across the hands depending on different parameters. Furthermore, this study highlights the importance of the positioning of the extremity dosemeter for a correct estimate of the maximum skin doses.
ORAMED项目的工作包4是一个由欧盟委员会在其第七框架计划下支持的合作项目（2008 - 11年），该工作包关注核医学中医护人员四肢剂量测定的优化。为了评估核医学科室医护人员手部的四肢剂量和剂量分布，欧洲32个核医学科室已启动了一项广泛的测量计划。这是通过使用标准方案记录所有与辐射暴露相关的信息来完成的，即辐射防护设备和工具。本研究展示了此次测量活动获得的初步结果。出于诊断目的，考虑了两种最常用的放射性核素：（99m）锝和（18）氟。对于治疗性治疗，选择了泽娃灵（Zevalin®）和多他曲肽（DOTATOC，均用（90）钇标记）。根据不同参数，手部剂量存在很大差异。此外，本研究强调了四肢剂量计定位对于正确估计最大皮肤剂量的重要性。
